Investigating RELEARN Neurofeedback as Treatment for Chronic Musculoskeletal Pain

Exclusion Criteria

• •Participants who meet any of the below criteria will be excluded from the investigation:
• •5. Pregnant or lactating woman
• •6. Use of opioids or cannabis
• •7. Active drug addiction defined as the use of cannabis, opioids, or other drugs
• •8. Previous or current neurologic, systemic, or mental illness, including any liver, kidney or metabolic disease.
• •9. Rheumatoid arthritis
• •10. Evidence of other pain types such as visceral, neuropathic, or malignant pain.
• •11. Evidence of other sources of ongoing pain such as root affect, traumas, or congenital malformation
• •12. Severe inflammation in the area of interest
• •13. Blindness or deafness
• •14. Consumption of alcohol, caffeine, nicotine on test day
• •15. Recent history of fractures or surgery in the area of interest
• •16. Participation in other clinical trials throughout the study period and one month prior to participation
• •17. History of epilepsy
• •18. Obesity class III and above. I.e. BMI \> 39,9